PrEP - Pre-exposure prophylaxis

Pre-exposure prophylaxis uptake concerns in the Democratic Republic of the Congo: Key population and healthcare workers perspectives

Nov 13, 2023

Authors: Yanhan Shen, Julie Franks, William Reidy, Halli Olsen, Chunhui Wang, Nadine Mushimbele, Richted Tenda Mazala, Tania Tchissambou, Faustin Malele, Apolinaire Kilundu, Trista Bingham, Gaston Djomand, Elie Mukinda, Raimi Ewetola, Elaine J Abrams, Chloe A...

Awareness of and willingness to use oral pre-exposure prophylaxis (PrEP) for HIV prevention among sexually active adults in Malawi: results from the 2020 Malawi population-based HIV impact assessment

Oct 23, 2023

Authors: Alinune Nathanael Kabaghe, Victor Singano, Danielle Payne, Alice Maida, Rose Nyirenda, Kelsey Mirkovic, Andreas Jahn, Pragna Patel, Kristin Brown, Mansoor Farahani, Felix Kayigamba, Lyson Tenthani, Francis Ogollah, Andrew Auld, Fatima Zulu, Wezi Msungama,...

ICAP’s Pre-exposure Prophylaxis (PrEP) Package (2023)

Oct 20, 2023

ICAP at Columbia University developed the Pre-exposure Prophylaxis (PrEP) Package 2023 to promote the introduction and implementation of multiple PrEP products. The material is designed to provide healthcare teams with the knowledge and skills to counsel clients about...

Biobehavioral Survey Among People Who Inject Drugs in Zambia

Sep 26, 2023

The first biobehavioral survey (BBS) among people who inject drugs (PWID) was conducted in three towns in Zambia from November 2021 to February 2022. The BBS estimated the prevalence of HIV, recent HIV infection, active syphilis, hepatitis B (HBV), hepatitis C (HCV),...

The use of oral HIV pre-exposure prophylaxis among people who inject drugs: barriers, and recommendations

Sep 22, 2023

Authors: Tafadzwa Dzinamarira, Enos Moyo Abstract: Globally, it is estimated that 296 million people used illicit drugs in 2021, which was a 23% increase from the number reported in 2011. Of the drug users in 2021, about 13 million were injection drug users. The...

1 2 3 … 7 Next

PrEP - Pre-exposure prophylaxis

Pre-exposure prophylaxis uptake concerns in the Democratic Republic of the Congo: Key population and healthcare workers perspectives

Awareness of and willingness to use oral pre-exposure prophylaxis (PrEP) for HIV prevention among sexually active adults in Malawi: results from the 2020 Malawi population-based HIV impact assessment

ICAP’s Pre-exposure Prophylaxis (PrEP) Package (2023)

Biobehavioral Survey Among People Who Inject Drugs in Zambia

The use of oral HIV pre-exposure prophylaxis among people who inject drugs: barriers, and recommendations

Enter keyword:

Select a category:

Select a tag:

Select a location:

Subscribe To Our Newsletter

Please check your email to confirm your subscription.